Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action

The use of onabotulinumtoxinA (BoNT-A) for the treatment of lower urinary tract diseases (LUTD) has increased markedly in recent years. The indications for BoNT-A treatment of LUTD now include neurogenic or idiopathic detrusor overactivity, interstitial cystitis/bladder pain syndrome and voiding dys...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhang, Jia-Fong, Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848644/
https://www.ncbi.nlm.nih.gov/pubmed/27110822
http://dx.doi.org/10.3390/toxins8040120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848644/
https://www.ncbi.nlm.nih.gov/pubmed/27110822
http://dx.doi.org/10.3390/toxins8040120

Ejemplares similares